The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(10,13-dimethyl-3,7,12-trioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ID: ALA4093171
Cas Number: 7276-59-7
PubChem CID: 2975
Max Phase: Preclinical
Molecular Formula: C24H34O5
Molecular Weight: 402.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(CCC(=O)O)C1CCC2C3C(=O)CC4CC(=O)CCC4(C)C3CC(=O)C12C
Standard InChI: InChI=1S/C24H34O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29)
Standard InChI Key: OHXPGWPVLFPUSM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
21.2256 -4.9692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7775 -5.5832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5854 -5.4130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8373 -4.6246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6452 -4.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1969 -5.0683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9013 -3.6701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5212 -6.3674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7370 -6.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7370 -7.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0238 -7.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3108 -7.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3107 -6.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0238 -6.2089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0238 -5.3836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5934 -7.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5934 -8.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8802 -9.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1671 -8.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1671 -7.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8802 -7.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4539 -9.0955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3108 -9.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0238 -8.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7370 -9.0955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5934 -7.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5212 -7.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0062 -7.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8228 -5.8007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
5 7 1 0
2 8 1 0
8 9 1 0
10 9 1 0
10 11 1 0
12 11 1 0
13 12 1 0
14 13 1 0
9 14 1 0
14 15 2 0
12 16 1 0
17 16 1 0
17 18 1 0
19 18 1 0
20 19 1 0
21 20 1 0
16 21 1 0
19 22 2 0
23 17 1 0
24 23 1 0
11 24 1 0
24 25 2 0
16 26 1 0
27 10 1 0
28 27 1 0
8 28 1 0
9 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.53Molecular Weight (Monoisotopic): 402.2406AlogP: 4.07#Rotatable Bonds: 4Polar Surface Area: 88.51Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.35CX Basic pKa: ┄CX LogP: 3.64CX LogD: 0.71Aromatic Rings: ┄Heavy Atoms: 29QED Weighted: 0.77Np Likeness Score: 2.26
References 1. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681 ] [10.1124/dmd.112.047068 ] 2. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402 ]